Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 18/20 | 0.80 |
| ▸ | MMP1 | P03956 | 16/20 | 0.80 |
| ▸ | PGR | P06401 | 4/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.79 |
| ▸ | MEN1 | O00255 | 1/20 | 0.79 |
| ▸ | USP2 | O75604 | 1/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.79 |
| ▸ | MLNR | O43193 | 1/20 | 0.73 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.73 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.73 |
| ▸ | LMNA | P02545 | 1/20 | 0.73 |
| ▸ | MAPT | P10636 | 1/20 | 0.73 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.73 |
| ▸ | PPARG | P37231 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4624245 | 1.00 | NR3C1 (0.80) | NR3C1MMP1PGRCYP3A4MEN1 | |
| SCHEMBL4624243 | 1.00 | NR3C1 (0.80) | NR3C1MMP1PGRCYP3A4MEN1 | |
| SCHEMBL9159208 | 0.93 | NR3C1 (0.85) | NR3C1MMP1PGRCYP3A4MEN1 | |
| SCHEMBL9159212 | 0.93 | NR3C1 (0.85) | NR3C1MMP1PGRCYP3A4MEN1 | |
| SCHEMBL7547 | 0.93 | NR3C1 (0.83) | NR3C1MMP1PGRCYP3A4MEN1 | |
| SCHEMBL6986508 | 0.93 | NR3C1 (0.83) | NR3C1MMP1PGRCYP3A4MEN1 | |
| SCHEMBL11812693 | 0.93 | NR3C1 (0.83) | NR3C1MMP1PGRCYP3A4MEN1 | |
| SCHEMBL9160605 | 0.92 | NR3C1 (0.83) | NR3C1MMP1PGRCYP3A4MEN1 | |
| SCHEMBL25372269 | 0.92 | NR3C1 (0.87) | NR3C1MMP1PGRCYP3A4MEN1 | |
| SCHEMBL9768478 | 0.92 | NR3C1 (0.87) | NR3C1MMP1PGRCYP3A4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1344526-B1 | PREVENTIVES/REMEDIES FOR INFLAMMATORY AIRWAY DISEASES | NIPPON SHINYAKU CO LTD (JP) | 2008-05-28 | — | — | EP | claimed |
| US-7214672-B2 | Preventives/remedies for inflammatory airway diseases | NIPPON SHINYAKU CO., LTD. (JP) | 2007-05-08 | — | — | US | claimed |
| US-20040053904-A1 | Preventive/ermedies for inflammatory airway diseases | NIPPON SHINYAKU CO., LTD. (JP) | 2004-03-18 | — | — | US | claimed |
| EP-1344526-A1 | PREVENTIVES/ERMEDIES FOR INFLAMMATORY AIRWAY DISEASES | SSP Co., Ltd. (JP) | 2003-09-17 | — | — | EP | claimed |
| JP-2279694-A | — | — | None | — | — | JP | disclosed |
| US-20050163724-A1 | Powdery respiratory tonic composition | SSP CO., LTD. (JP) | 2005-07-28 | — | — | US | disclosed |
| EP-1514549-A1 | POWDERY RESPIRATORY TONIC COMPOSITION | SSP Co., Ltd. (JP) | 2005-03-16 | — | — | EP | disclosed |
| EP-0393658-B1 | Novel steroid derivatives | SS PHARMACEUTICAL CO (JP) | 1995-03-22 | — | — | EP | disclosed |
| US-5063222-A | Antiinflammatory, rheumatism | SS PHARMACEUTICAL CO., LTD. (JP) | 1991-11-05 | — | — | US | disclosed |
| US-5063222-A | Antiinflammatory, rheumatism | SS PHARMACEUTICAL CO., LTD. (JP) | 1991-11-05 | — | — | US | disclosed |
| JP-H02279694-A | NOVEL STEROID DERIVATIVE | SS PHARMACEUT CO LTD | 1990-11-15 | — | — | JP | disclosed |
| EP-0393658-A2 | Novel steroid derivatives | SS PHARMACEUTICAL CO., LTD. (JP) | 1990-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040053904-A1 | Preventive/ermedies for inflammatory airway diseases | NR3C1, OXER1, NR5A1 | NR3C1 1/4885MMP1 234/4885PGR 1911/4885 |
| US-20050163724-A1 | Powdery respiratory tonic composition | IL5, IL17A, RORC | NR3C1 12/4885MMP1 153/4885PGR 1432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.